F.D.A. Deals Setback to Catalyst in Race for Drug Approval
Wednesday, February 17, 2016 - 14:41
in Physics & Chemistry
Catalyst Pharmaceuticals, vying for exclusive rights to a drug called Firdapse, said it received a letter saying its application was incomplete.